EPO Enlarged Board establishes new practice in transfers of priority rights

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2025

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

EPO Enlarged Board establishes new practice in transfers of priority rights

Sponsored by

maiwald-logo-cropped.PNG
pexels-rodolfoclix-1036936.jpg

Michaela Weigel-Krusemarck of Maiwald considers the impact of the Enlarged Board of Appeal introducing a rebuttable presumption that a patent applicant is entitled to claim priority

The EPO’s Enlarged Board of Appeal has decided that the transfer of a priority right is to be assessed solely according to the European Patent Convention (EPC). The Enlarged Board of Appeal’s consolidated decision G 1/22 and G 2/22 on October 10 2023 means national law will no longer be considered, thus departing from the previous practice (for example, T 1201/14).

Background to the decision

Due to the former need in the US to file a patent application in the name of the inventors, the EPO often confronted the scenario that a European patent (EP) application derived from a Patent Cooperation Treaty (PCT) application claimed the priority of a US application, wherein the applicants of the priority application differed from the applicants of the subsequent application. Whether there was an effective transfer of rights from the applicants of the US priority application to the applicants of the subsequent PCT or EP application was then (usually) examined by the EPO under US law. However, this is no longer the case.

According to the decision G 1/22 and G 2/22, an implicit agreement – for example, an implied transfer – is sufficient for a valid transfer, as the EPC does not have any formal requirements for the transfer of a priority right.

The Enlarged Board of Appeal has established a rebuttable presumption that the applicant is entitled to claim priority. This shifts the burden of proof to the effect that the party contesting the right to priority must prove that this right is actually lacking. The intention of the Enlarged Board of Appeal is to ensure that the priority is challenged less frequently in opposition proceedings.

Introduction of an implied agreement approach

The Enlarged Board of Appeal explicitly leaves open the question of the so-called PCT joint applicants approach. Instead, the Enlarged Board of Appeal establishes the concept of an implied agreement; according to which, the mere fact of the joint filing of a subsequent PCT application is sufficient for the parties to apparently have entered into an implicit agreement to the effect that an additional subsequent applicant may invoke the priority right conferred by the filing of the priority application by another subsequent applicant or other subsequent applicants.

Such an agreement may only be implied if all the applicants of the priority application or their successors in title (‘all applicants’) are also applicants of the subsequent application. However, even if this is not the case, the rebuttable presumption in favour of the priority right of the subsequent applicants still applies.

In this context, it is interesting to look back at the decision T 844/18 (CRISPR) in 2020, in which the board of appeal denied the validity of the priority claim due to violation of the ‘all applicants’ requirement. Against the background of the new decision by the Enlarged Board of Appeal, it is questionable as to what extent the application of the rebuttable presumption would have led to a different result in the above case.

Application of the new concepts

It remains to be seen how the opposition divisions and boards of appeal will implement the new concepts introduced by the Enlarged Board of Appeal in G 1/22 and G 2/22; for example, standards for rebutting the presumption. However, Dr. Martin Huenges and Dr. Kerstin Wolff, respectively a partner and counsel at Maiwald, who are familiar with the consolidated appeal cases T 2360/19, T 2516/19, and T 2689/19 due to their involvement in other CRISPR cases, report that the decision will be based on the new concepts of the Enlarged Board of Appeal, and the presumption of priority entitlement could not be rebutted in these cases.

Meanwhile, the Federal Court of Justice has already adopted this new EPO case law; for example, in Sorafenib-Tosylat and Happy Bit (linked-to pages in German).

more from across site and SHARED ros bottom lb

More from across our site

News of a breakaway firm launching in Germany and a spike in vaccine-related patent applications were also among the top talking points
A flurry of hiring activity among UK firms suggests they are confident of mounting a serious challenge at the UPC
With the submission deadline approaching, we sat down with our research team to provide top tips on how to make your firm stand out
EA, owner of video games including Madden and The Sims, will be sold to a consortium including Saudi Arabia’s Public Investment Fund and a firm owned by Donald Trump’s son-in-law
New arrival marks Mewburn Ellis' second partner hire in ten days as firm looks to boost patent litigation and prosecution capabilities
In-house counsel and teams are invited to submit information for the 21st annual Managing IP Awards
The 2025 list of Rising Stars and Corporate Stars, produced by Managing IP’s accreditation title IP STARS, is now available
Eszter Szakács, partner at Danubia in Hungary, discusses women’s progression, workplace flexibility, and how to deal with imposter syndrome
Rob Fewery is a solicitor at Allwyn Entertainment in the UK
Piotr Rafalski is a patent attorney at Qemetica in Poland
Gift this article